1-7 of 7
Claude Chahine, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Feasibility and Benefit of Molecularly-Informed Enrollment into Early Phase Clinical Trials for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Jean-Marie Michot, MD, Valérie Camara-clayette, Audrey Detolle, Claude Chahine, MD, Julien Lazarovici, MD, Alina Danu, MD, Jacques Bosq, David Ghez, MD PhD, Peggy Dartigues-Cuillères, MD, Julia Arfi-Rouche, Rastilav Bahleda, Wassila Rahali, Andrea Varga, Capucine Baldini, Lambros Tselikas, Clélia Paume, Helene Lecourt, Sophie Cotteret, Veronique Vergé, Jean-Charles Soria, Christophe Massard, Vincent Ribrag, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4110.
https://doi.org/10.1182/blood-2018-99-110852
Published: 2018
Journal Articles

Immunological Cytopenias Induced By Anti-Programmed Cell Death (ligand) 1 Antibodies

Jean-Marie Michot, MD, Nicolas Delanoy, Thibault Comont, Nora Kramkimel, Romain Dupont, Julien Lazarovici, MD, Stéphane Champiat, Caroline Robert, Charles Herbaux, MD, Benjamin Besse, Claude Chahine, MD, Aude Guillemin, Christine Mateus, Patricia Pautier, Philippe Saiag, Emmanuela Madonna, Marie Maerevoet, MD, Jean-Christophe Bout, Charlotte Leduc, Pascal Biscay, Gilles Quere, Christophe Nardin, Mikael Ebbo, Laurence Albiges, Grégoire Marret, Virginie Levrat, Cécile Dujon, Salim Laghouati, Laure Croisille, MD PhD, Anne-Laure Voisin, Bertrand Godeau, MD, Christophe Massard, Vincent Ribrag, MD, Aurelien Marabelle, MD PhD, Marc Michel, Olivier Lambotte
Journal: Blood
Blood (2018) 132 (Supplement 1): 2412.
https://doi.org/10.1182/blood-2018-99-110875
Published: 2018
Journal Articles

Outcomes of Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Included in Phase I Clinical Trials

Marion Brault, Maxime Annereau, PharmD, Alina Danu, MD, Julien Lazarovici, MD, Claude Chahine, MD, Andrea Varga, Capucine Baldini, Stéphane Champiat, Malik Berhoune, Christophe Massard, François Lemare, Vincent Ribrag, MD, Jean-Marie Michot, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2992.
https://doi.org/10.1182/blood-2018-99-112919
Published: 2018
Journal Articles

Dose-Adjusted Rituximab Mini-CYVE (CYtarabine bolus, VEpeside and dexamethasone) for Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma Not Eligible for High Dose Therapy

Yolla EL Dakdouki, Jean-Marie Michot, MD, Julien Lazarovici, MD, Khalil Saleh, MD, David Ghez, MD PhD, Claude Chahine, MD, Loic Verlingue, Christophe Willekens, MD, Veronique Vergé, Christophe Ferme, MD, Alina Danu, MD, Vincent Ribrag, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2847.
https://doi.org/10.1182/blood.V130.Suppl_1.2847.2847
Published: 2017
Journal Articles

The Impact of Risk-Adapted Treatment Strategy on Outcome of Patients with Acute Myeloid Leukemia Aged ≥ 60 Years after Allogeneic Stem Cell Transplantation

Riwa Sakr, MD, Sylvain Pilorge, MD, Stephane De Botton, Claude Chahine, MD, Tereza Coman, MD PhD, Marcel Adler, MD, Jean-Baptiste Micol, MD PhD, Florence Pasquier, MD PhD, Christophe Willekens, MD, Alina Danu, MD, Julien Lazarovici, MD, David Ghez, MD PhD, Eric Solary, MD, Vincent Ribbag, Jean-Henri Bourhis, Cristina Castilla-LLorente, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5544.
https://doi.org/10.1182/blood.V130.Suppl_1.5544.5544
Published: 2017
Journal Articles

Repetitive Low-Dose Radiation Therapies As an Alternative Option for Indolent Non-Hodgkin Lymphoma

Khalil Saleh, MD, Jean-Marie Michot, MD, Alina Danu, MD, Julien Lazarovici, MD, Nadine Khalifé-Saleh, MD, David Ghez, PhD MD, Claude Chahine, MD, Yolla Dakdouki, MD, Jonathan Fahri, Resident, Christophe Willekens, MD, Angela Boros, MD, Julia Arfi-Rouche, MD, Pierre Maroun, MD, Eric Deutsch, PhD MD, Vincent Ribrag, MD, Renaud Mazeron, MD
Journal: Blood
Blood (2016) 128 (22): 1784.
https://doi.org/10.1182/blood.V128.22.1784.1784
Published: 2016
Journal Articles

BRAF V600E Targetable Mutation in Relapsed/Refractory Multiple Myeloma (R/R MM) Patients: A High Incidence in R/R MM Detected Using Cell Sorting Screening

Alina Danu, MD, Sophie Cotteret, PhD, Ludovic Lacroix, Véronique Saada, PharmD, Véronique Vergé, MD, Nathalie Auger, Julien Lazarovici, MD, Edith Carton, Jonathan Farhi, Khalil Saleh, MD, David Ghez, PhD MD, Claude Chahine, MD, Jean-Marie Michot, MD, Vincent Ribrag, MD
Journal: Blood
Blood (2016) 128 (22): 5638.
https://doi.org/10.1182/blood.V128.22.5638.5638
Published: 2016